Chullin 36

Hook

Every founder faces the "gray zone" dilemma: you have a decision that isn’t strictly illegal or clearly prohibited by your internal handbook, but it feels “off.” Your legal counsel might say you’re in the clear, but your gut—your Mensch instinct—is screaming that the action carries a subtle, lingering stain. In the high-stakes world of startup growth, we often rationalize these gray areas by saying, "It’s just business" or "We’ll fix the process later."

The Talmud in Chullin 36 presents a masterclass in this exact tension. The Sages debate the status of blood from consecrated animals—whether it’s a source of impurity or a neutral byproduct. The temptation is to treat the "byproducts" of our business decisions as benign simply because they aren't the core "product" we are selling. But the text warns us that the way we handle the peripheral elements of our operations—the "splashed blood"—defines our integrity. If you treat your side-effects as irrelevant, you eventually compromise the sanctity of the entire enterprise. This is for the founder who refuses to build on a foundation of "maybe it’s okay."

Text Snapshot

“It could enter your mind to say: Since benefit from disqualified consecrated animals is forbidden with regard to their fleece and labor, perhaps benefit from their blood is also forbidden... Therefore, the verse teaches us that benefit from their blood is permitted.” Chullin 36

“Rabbi Ḥiyya says: If the gourd came into contact with a source of impurity, one places the matter in abeyance, as there is uncertainty whether the blood rendered it susceptible to impurity.” Chullin 36

“The statement of one Sage has no standing in a place where it is disputed by two Sages.” Chullin 36

Analysis

Insight 1: The Fallacy of the "Peripheral" Benefit

The Talmud opens with a logical trap: because the primary animal is restricted, we assume its byproducts (fleece, labor, blood) are also restricted. The text clarifies that while the animal is holy, the blood—the byproduct—is permitted. In startup terms, founders often believe that if the core of their business is ethical, the "blood"—the aggressive tactics, the "growth-hack" shortcuts, or the grey-market data sourcing—should also be permissible. But the text forces a distinction. You must audit your periphery. If your "fleece" (your revenue) comes from "disqualified" sources, you cannot rely on the excuse that the core business is holy. As the Dor Revi’i notes on Chullin 36, the concern is that we might wrongly extend the sanctity of the animal to the blood, or conversely, assume the blood is as "forbidden" as the labor. Decision Rule: If your growth tactics or operational "byproducts" feel like they occupy a gray zone, stop trying to justify them by the legitimacy of your core product. Test the tactic on its own merit.

Insight 2: The Radical Honesty of "Abeyance"

Rabbi Ḥiyya introduces a brilliant, frustrating, and necessary concept: Tolin—placing the matter in abeyance. When there is uncertainty about whether a gourd has been rendered impure by the slaughter, he rules that you may neither eat it (treat it as pure) nor burn it (treat it as definitively impure). Most founders hate this. We want binary outcomes: "Is this growth hack 'growth' or 'spam'?" The Talmudic wisdom here is that in the absence of clarity, holding pattern is the only ethical move. If you aren't sure if your marketing email strategy is spam, or if your data collection is a violation of user trust, do not "eat" the lead. Do not "burn" your relationship with the customer. Pause. Acknowledge the uncertainty. The KPI here is your "Abeyance Ratio": the percentage of decisions made under uncertainty where you deliberately hit the "pause" button rather than rolling the dice.

Insight 3: The Authority of the Consensus (The "Two Against One" Rule)

The Talmud explicitly dismisses an individual’s opinion when it clashes with the collective wisdom of two other Sages: "The statement of one Sage has no standing in a place where it is disputed by two Sages." This is a foundational rule for corporate governance. Too many founders run "founder-led" dictatorships where their singular, biased perspective overrides the consensus of their leadership team. If two of your C-suite leaders—who are incentivized by different metrics (e.g., Legal vs. Sales)—both flag a strategy as ethically dubious, the founder’s "founder-intuition" should lose. Decision Rule: When the consensus of your team identifies a risk you are ignoring, you are effectively acting as the "one Sage" who has no standing. Yield to the collective. It’s not just a matter of team cohesion; it’s a safeguard against your own blind spots.

Policy Move

The "Abeyance" Review Process. Implement a formal "Abeyance Policy" for any product or growth initiative that falls into a "gray zone" of ethics or user trust.

1. The Trigger: Any initiative where legal counsel says "It’s not technically illegal" but the product or ethics team expresses concern.
2. The Policy: The project is placed in "Abeyance." It cannot be launched, nor can it be killed. It must be subjected to a 72-hour review by a cross-functional panel (including at least one person with no skin in the revenue game).
3. The KPI: Track the "Abeyance Trigger Rate." If you aren't hitting at least 2–3 items a quarter, you aren't looking hard enough at your "blood" (your peripheral operations). If you are hitting too many, your organizational strategy is likely fundamentally misaligned with your values.

Board-Level Question

"When we look at our current growth levers, which ones are we justifying solely because they aren't 'technically' prohibited, and how many of those would we be comfortable explaining to a customer who has full transparency into our decision-making process? If we are currently in a state of 'abeyance' regarding any of our internal processes, why haven't we made a binary decision to either clean them up or cut them out?"

Takeaway

Stop trying to force the "blood" into the same category as the "animal." Your core mission might be noble, but your methods define your character. When you face an ethical ambiguity, refuse the binary choice of "full speed ahead" or "total surrender." Embrace the power of the pause. In the kingdom of the Mensch, the ability to say "I don't know, so we wait" is not a sign of weakness—it is the ultimate display of executive authority. You don't build a lasting legacy on gray areas; you build it on the discipline of knowing when to stop.